Michael J. Quinn serves as Executive at CARDIOGENESIS CORP /CA, where they oversee executive responsibilities. Since joining the company, Michael J. Quinn has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 17, 2006 involved exercising options for 100,000 shares valued at $32.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 17, 2006 | CGCP | $32.0K | Option Exercise | 100,000 | $0.32 | Discretionary |
Michael J. Quinn currently holds 402,650 shares of CARDIOGENESIS CORP /CA (CGCP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Quinn has been a net neutral trader of CGCP stock. They have purchased $0 and sold $0 worth of shares.
Michael J. Quinn's most recent insider trade was on Mar 17, 2006, when they sold 100,000 shares at $0.32 per share.
Get notified when new Form 4 filings are submitted